| Preferred Name |
Didanosine |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C431 |
| ALT_DEFINITION |
A drug used to treat infection caused by viruses. |
| CAS_Registry |
69655-05-6 |
| CHEBI_ID |
CHEBI:490877 |
| Chemical_Formula |
C10H12N4O3 |
| code |
C431 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| DEFINITION |
A nucleoside reverse transcriptase inhibitor analog of adenosine. |
| FDA_UNII_Code |
K3GDH6OH08 |
| FULL_SYN |
Videx EC ddI Videx Dideoxyinosine 2',3'-Dideoxyinosine Didanosine EC |
| label |
Didanosine |
| Legacy_Concept_Name |
Didanosine |
| NSC_Code |
612049 |
| PDQ_Closed_Trial_Search_ID |
37814 |
| PDQ_Open_Trial_Search_ID |
37814 |
| Preferred_Name |
Didanosine |
| prefixIRI |
C431 |
| prefLabel |
Didanosine |
| Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide |
| UMLS_CUI |
C0012133 |
| subClassOf |